Daiichi Sankyo GAAP EPS of ¥117.28, revenue of ¥1533.46B; reaffirms FY outlook
Source: SeekingAlpha
2026-01-30 08:14:03 ET
More on Daiichi Sankyo Company
- Daiichi Sankyo Company, Limited (DSNKY) Q3 2026 Earnings Call Transcript
- Daiichi Sankyo Company, Limited (DSNKY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Daiichi Sankyo Company, Limited (DSNKY) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- AstraZeneca's Enhertu and Genentech's Perjeta combo gains breast cancer approval
- Daiichi Sankyo partnering with General Proximity on oncology targets
Read the full article on Seeking Alpha
For further details see:
Daiichi Sankyo GAAP EPS of ¥117.28, revenue of ¥1533.46B; reaffirms FY outlook
Daiichi Sankyo Co Ltd Sponsored ADR Level 1
NASDAQ: DSNKY
DSNKY Trading
-0.61% G/L:
$18.06 Last:
366,900 Volume:
$18.255 Open:
DSNKY Latest News
January 21, 2026 08:00:00 am
Daiichi Sankyo Unveils New Toronto Headquarters to Accelerate Investment and Innovation in Oncology
